Company Seeks Permission to Import Mystery Controlled Substances
Published Date: 11/26/2025
Notice
Summary
Noramco wants to become an official importer of some controlled substances like marijuana and methadone. If you’re a registered manufacturer or interested party, you have until December 26, 2025, to share your thoughts or ask for a hearing. This move could affect companies dealing with these drugs and might impact how these substances enter the U.S.
Analyzed Economic Effects
6 provisions identified: 2 benefits, 2 costs, 2 mixed.
Noramco applied to import listed controlled substances
On September 22, 2025, Noramco applied to be registered as an importer for multiple controlled substances, including Gamma Hydroxybutyric Acid (code 2010, Schedule I), Marihuana (7360, Schedule I), Tetrahydrocannabinols (7370, Schedule I), Methadone-Intermediate (9254, Schedule II), and various opium codes (e.g., 9600–9670, Schedule II). This notice publicly announces that application and identifies the exact drug codes the company seeks to import.
Planned import of Poppy Straw Concentrate (9670)
Noramco plans to import Poppy Straw Concentrate (drug code 9670) to bulk manufacture other controlled substances for distribution to its customers. This planned import is specifically for bulk manufacturing use and distribution to Noramco's customers.
Planned import of Tapentadol intermediate (9780)
Noramco plans to import an intermediate form of Tapentadol (drug code 9780) to bulk manufacture Tapentadol for distribution to its customers. The application states the intermediate will be used for bulk manufacture rather than finished product importation.
Synthetic CBD and THC import limits for marijuana codes
For drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), Noramco's application says it plans to import a synthetic cannabidiol and a synthetic Tetrahydrocannabinol. The notice also states that no other activities for these drug codes are authorized under this registration.
Finished dosage forms not authorized for import
The notice states that authorization will not extend to the import of Food and Drug Administration (FDA) approved or non-approved finished dosage forms for commercial sale. The registration is limited to activities consistent with 21 U.S.C. 952(a)(2).
Comment and hearing request deadline: Dec 26, 2025
Registered bulk manufacturers of the affected classes and other applicants may submit electronic comments, objections, or a written request for a hearing on Noramco's application on or before December 26, 2025. Comments must be submitted via regulations.gov; hearing requests have specified mailing addresses in Springfield, VA.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in